Polish registry tracking people with diabetes and diabetes risk
Records detailed health data from people with diabetes or high diabetes risk.
Plain-language title generated from the registry record
Registry title: Polish Registry of Diabetes (PolReD)
Key facts
- Where
- Bialystok, PolandSee the site
Where in Poland
- Clinical Research Centre, Medical University of BialystokBialystok, PolandTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Medical University of Bialystok
- Trial code
- NCT04657367
- Record updated
- 26 March 2025
- Original description
The aim of this project is to create a registry of diabetic patients, containing a detailed clinical profile of each patient, along with omics data, which will be analyzed using artificial intelligence algorithms, and their results will be implemented in the form of new recommendations of care for high-risk patients and those already suffering from diabetes.Read full original descriptionShow less
Polish Registry of Diabetes - PL: Polski Rejestr Diabetologiczny (PolReD)
The aim of this project is to create a registry of diabetic patients, containing a detailed clinical profile of each patient, along with omics data, which will be analyzed using artificial intelligence algorithms, and their results will be implemented in the form of new recommendations of care for high-risk patients and those already suffering from diabetes.
The study will be conducted prospectively. The project participants will be patients with diabetes, patients at high risk of developing diabetes and a control group of normoglycemic patients who will participate in study visits at the Clinical Research Center of the Medical University of Bialystok.
Inclusion: patients with diagnosed diabetes (according to the American Diabetes Association criteria) - diabetes group; patients with diagnosed prediabetes (IFG and/or IGT) - prediabetes group; patients with normoglycemia (NFG and NGT) - normoglycemia group; informed consent.
Exclusion: drug addiction; severe psychiatric disorders; patients with gestational diabetes mellitus; patients unable to give informed consent, legally incompetent or incapable to comply with the study terms and conditions.